Breast Cancer Clinical Trial
YES Study – Newly Diagnosed/Metastatic Intervention
Summary
This research study is being done to monitor common symptoms and behavior, and to provide supportive care information and peer support, as well as research opportunities for young women ages of 18-39 years old who have been diagnosed with stage 0-IV stage breast cancer using a web-based portal (YES), built for smartphones, tablets, and computers.
Full Description
This is a prospective, interventional cohort study with an embedded Phase II randomized controlled clinical trial with a parallel design.
The research study procedures include screening for eligibility, consent, enrolled, randomization into 1 of 4 groups.
The study interventions including the (web-based portal ) YES portal use including regular assessments, serial outcome surveys, medical record review, and tumor/blood collection.
The YES portal is a web-based portal designed for access by smartphone, tablet, or laptop/desktop. The portal is designed to help monitor cancer related issues and to share self-management information and resources to those interested in particular issues or who score high enough on the symptom measures designed to assess and track noticeable symptoms (and thus might benefit from such), as well as to share potential research opportunities when available. The portal is also designed to create a community among participants through the yeschat.org discussion board
Participants will be in this research study for up to 5 years with the option to opt out of portal assessment component follow-up after only 1 year.
It is expected that about 400 people will take part in this research study
Eligibility Criteria
Inclusion Criteria:
Stage 0-3
Female
diagnosed with breast cancer between the ages of 18-39 years
less than 3 months post diagnosis date of new primary or local recurrence (prior history of other cancer is allowed as long as treated with curative intent and no evidence of disease from that cancer)
has not started treatment for breast cancer diagnosis yet
is planning to get care at DFCI
be fluent in and able to read English
have internet access on a regular basis at the time of consent that can support the web-based platform
Stage IV
Female
initial diagnosis of breast cancer between the ages of 18-39 years
be fluent in and able to read English
have internet access on a regular basis at the time of consent that can support the web-based platform
Exclusion Criteria:
-
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02215, United States More Info
Principal Investigator
How clear is this clinincal trial information?